Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies
- PMID: 32851962
- DOI: 10.2174/1568026620666200826122402
Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies
Abstract
Central nervous system (CNS) cancers are among the most common and treatment-resistant diseases. The main reason for the low treatment efficiency of the disorders is the barriers against targeted delivery of anticancer agents to the site of interest, including the blood-brain barrier (BBB) and blood-brain tumor barrier (BBTB). BBB is a strong biological barrier separating circulating blood from brain extracellular fluid that selectively and actively prevents cytotoxic agents and majority of anticancer drugs from entering the brain. BBB and BBTB are the major impediments against targeted drug delivery into CNS tumors. Nanotechnology and its allied modalities offer interesting and effective delivery strategies to transport drugs across BBB to reach brain tissue. Integrating anticancer drugs into different nanocarriers improves the delivery performance of the resultant compounds across BBB. Surface engineering of nanovehicles using specific ligands, antibodies and proteins enhances the BBB crossing efficacy as well as selective and specific targeting to the target cancerous tissues in CNS tumors. Multifunctional nanoparticles (NPs) have brought revolutionary advances in targeted drug delivery to brain tumors. This study reviews the main anatomical, physiological and biological features of BBB and BBTB in drug delivery and the recent advances in targeting strategies in NPs-based drug delivery for CNS tumors. Moreover, we discuss advances in using specific ligands, antibodies, and surface proteins for designing and engineering of nanocarriers for targeted delivery of anticancer drugs to CNS tumors. Finally, the current clinical applications and the perspectives in the targeted delivery of therapeutic molecules and genes to CNS tumors are discussed.
Keywords: Blood-brain barrier; Blood-brain tumor barrier drug delivery; Brain tumors; Central nervous system; Drug transport; Ligand targeting; Targeted drug delivery.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.J Neuroimmune Pharmacol. 2017 Mar;12(1):84-98. doi: 10.1007/s11481-016-9698-1. Epub 2016 Jul 23. J Neuroimmune Pharmacol. 2017. PMID: 27449494 Review.
-
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.Part Fibre Toxicol. 2010 Mar 3;7:3. doi: 10.1186/1743-8977-7-3. Part Fibre Toxicol. 2010. PMID: 20199661 Free PMC article. Review.
-
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.Int J Pharm. 2019 Mar 25;559:360-372. doi: 10.1016/j.ijpharm.2019.01.056. Epub 2019 Feb 2. Int J Pharm. 2019. PMID: 30721725 Review.
-
Recent progress of drug nanoformulations targeting to brain.J Control Release. 2018 Dec 10;291:37-64. doi: 10.1016/j.jconrel.2018.10.004. Epub 2018 Oct 9. J Control Release. 2018. PMID: 30308256 Review.
-
The blood-brain barriers: novel nanocarriers for central nervous system diseases.J Nanobiotechnology. 2025 Feb 26;23(1):146. doi: 10.1186/s12951-025-03247-8. J Nanobiotechnology. 2025. PMID: 40011926 Free PMC article. Review.
Cited by
-
Application of Non-Viral Vectors in Drug Delivery and Gene Therapy.Polymers (Basel). 2021 Sep 28;13(19):3307. doi: 10.3390/polym13193307. Polymers (Basel). 2021. PMID: 34641123 Free PMC article. Review.
-
Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma.Front Oncol. 2021 Mar 22;11:633827. doi: 10.3389/fonc.2021.633827. eCollection 2021. Front Oncol. 2021. PMID: 33869019 Free PMC article. Review.
-
Phenolic-enabled nanotechnology: a new strategy for central nervous system disease therapy.J Zhejiang Univ Sci B. 2024 Oct 15;25(10):890-913. doi: 10.1631/jzus.B2300839. J Zhejiang Univ Sci B. 2024. PMID: 39420524 Free PMC article. Review.
-
Micro/Nanosystems for Magnetic Targeted Delivery of Bioagents.Pharmaceutics. 2022 May 26;14(6):1132. doi: 10.3390/pharmaceutics14061132. Pharmaceutics. 2022. PMID: 35745705 Free PMC article. Review.
-
Exploring the Potentials of Hyaluronic Acid-coated Polymeric Nanoparticles in Enhanced Cancer Treatment by Precision Drug Delivery, Tackling Drug Resistance, and Reshaping the Tumour Micro Environment.Curr Med Chem. 2025;32(20):3960-3999. doi: 10.2174/0109298673302510240328050115. Curr Med Chem. 2025. PMID: 38571347 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources